Trials / Conditions / Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma

Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma

7 registered clinical trials studyying Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma.

Status	Trial	Sponsor	Phase
Terminated	Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malig NCT03272633	Rutgers, The State University of New Jersey	EARLY_Phase 1
Completed	Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Ma NCT02342782	City of Hope Medical Center	Phase 1
Active Not Recruiting	Study of Pembrolizumab (MK-3475) in Combination With Romidepsin NCT03278782	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Active Not Recruiting	Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripher NCT03011814	City of Hope Medical Center	Phase 1 / Phase 2
Completed	Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas NCT01897012	National Cancer Institute (NCI)	Phase 1
Completed	Ruxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell NCT01431209	University of Nebraska	Phase 2
Completed	Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin L NCT01035463	University of Nebraska	Phase 1 / Phase 2